Longitude Venture Partners L.P. Insider Profile
4 Followers
Longitude Venture Partners L.P., Director, Ten Percent Owner at Corcept Therapeutics, holds 14.71M shares in Corcept Therapeutics (Ticker: CORT).
Longitude Venture Partners L.P.'s Trading History
| CORTCorcept Therapeutics | Nov 30, 2016 | Director, Ten Percent Owner | Uninformative Sell | ― | $1.07B | |
CORT Insider Shares: 14.71M (13.52%) | ||||||
You May Also Like
Longitude Venture Partners L.P. insider profile FAQ
What is the percentage of profitable transactions made by Longitude Venture Partners L.P.?
The percentage of profitable transactions made by Longitude Venture Partners L.P. is 0%.
What is the average return per transaction made by Longitude Venture Partners L.P.?
The average return per transaction made by Longitude Venture Partners L.P. is -72.00%.
What stocks does Longitude Venture Partners L.P. hold?
Longitude Venture Partners L.P. holds: CORT stocks.
What was Longitude Venture Partners L.P.'s most profitable transaction?
Longitude Venture Partners L.P.’s most profitable transaction was an Informative Buy of CORT stock on April 1, 2015. The return on the trade was -16.40%.
What is Longitude Venture Partners L.P.'s role in Corcept Therapeutics?
Longitude Venture Partners L.P.'s role in Corcept Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
